VEGFA and melanoma: We have demonstrated that ixolaris blocks the primary growth of human glioblastoma (U87-MG) and murine melanoma (B16F10) cells in animal models, and this effect is accompanied by a significant decrease in VEGF expression as well as diminished tumour angiogenesis [127,128].